Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials (Q71102203)
Jump to navigation
Jump to search
scientific article published on 01 June 1996
Language | Label | Description | Also known as |
---|---|---|---|
English | Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials |
scientific article published on 01 June 1996 |
Statements
Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials (English)
Buzdar AU
Smith R
Vogel C
Bonomi P
Keller AM
Favis G
Mulagha M